In all, these results supported our molecular findings that DSG3 functions as an oncogene in head-neck cancer through the DSG3-plakoglobin-CF/LEF - myc/cyclinD3/MMP signaling pathway. This evidence concerns the gene CCND3 and head and neck cancer.